Intra‐arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial

BACKGROUND: There are no known treatments that halt or reverse chronic kidney disease (CKD) in cats. In rodent models, stem cell treatment has been associated with improvement in renal function parameters, especially when stem cells were delivered intra‐arterially to the kidney. To date, only IV and...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Abigail L., Berent, Allyson C., Weisse, Chick, Langston, Catherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524114/
https://www.ncbi.nlm.nih.gov/pubmed/30924554
http://dx.doi.org/10.1111/jvim.15486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524114/
https://www.ncbi.nlm.nih.gov/pubmed/30924554
http://dx.doi.org/10.1111/jvim.15486

Ejemplares similares